TORONTO, Aug. 21, 2023 /CNW/ - Dan Legault, Chief Executive Officer and Director, Antibe Therapeutics Inc. (TSX:ATE.TO) shares his Company's story in an interview with TMX Group.
Read more at newswire.caToronto Stock Exchange, Antibe Therapeutics Inc., View From The C-Suite
Newswire.ca - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here